Cargando…

CD26 as a Promising Biomarker for Predicting Prognosis in Patients with Pancreatic Tumors

PURPOSE: Pancreatic cancer is associated with a high mortality rate owing to insufficient approaches for early diagnosis and the invasive biological behavior of the cancer. CD26 is a membrane-anchored protein involved in multiple physiological and pathological processes. Here, we investigated correl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Liang, Tian, Xiuyun, Ye, Chunxiang, Guan, Xiaoya, Dong, Bin, Zhao, Min, Wu, Jianhui, Hao, Chunyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7737554/ https://www.ncbi.nlm.nih.gov/pubmed/33335402 http://dx.doi.org/10.2147/OTT.S278736

Ejemplares similares

Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma
por: Wang, Weijia, et al.
Publicado: (2021)

Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features
por: Tian, Xiuyun, et al.
Publicado: (2015)

Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer
por: Wang, Weijia, et al.
Publicado: (2023)

PTK7 overexpression in colorectal tumors: Clinicopathological correlation and prognosis relevance
por: Tian, Xiuyun, et al.
Publicado: (2016)

T cell receptor β‐chain repertoire analysis of tumor‐infiltrating lymphocytes in pancreatic cancer
por: Cui, Can, et al.
Publicado: (2018)

SKP2 High Expression, KIT Exon 11 Deletions, and Gastrointestinal Bleeding as Predictors of Poor Prognosis in Primary Gastrointestinal Stromal Tumors
por: Lv, Ang, et al.
Publicado: (2013)

Anti-Tumor Effect of Apatinib and Relevant Mechanisms in Liposarcoma
por: Cui, Lixuan, et al.
Publicado: (2021)

Comprehensive immune characterization and T‐cell receptor repertoire heterogeneity of retroperitoneal liposarcoma
por: Yan, Liang, et al.
Publicado: (2019)

Tsp2 Facilitates Tumor-associated Fibroblasts Formation and Promotes Tumor Progression in Retroperitoneal Liposarcoma
por: Xu, Chang, et al.
Publicado: (2022)

Identification of TYMS as a promoting factor of retroperitoneal liposarcoma progression: Bioinformatics analysis and biological evidence
por: Zhang, Sha, et al.
Publicado: (2020)

Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence
por: Cui, Lixuan, et al.
Publicado: (2022)

Expression of SATB1 Promotes the Growth and Metastasis of Colorectal Cancer
por: Zhang, Yi, et al.
Publicado: (2014)

Downregulation of RRM2 Attenuates Retroperitoneal Liposarcoma Progression via the Akt/mTOR/4EBP1 Pathway: Clinical, Biological, and Therapeutic Significance
por: Zhang, Sha, et al.
Publicado: (2020)

Downregulation of TfR1 promotes progression of colorectal cancer via the JAK/STAT pathway
por: Cui, Can, et al.
Publicado: (2019)

Brain natriuretic peptide and cardiac troponin I for prediction of the prognosis in cancer patients with sepsis
por: Yang, Yong, et al.
Publicado: (2021)

Features and Treatment of Peritoneal Metastases from Solid Pseudopapillary Neoplasms of the Pancreas
por: Wu, Jianhui, et al.
Publicado: (2018)

Development and validation of a nomogram for predicting the prognosis in cancer patients with sepsis
por: Yang, Yong, et al.
Publicado: (2022)

Establishment and evaluation of retroperitoneal liposarcoma patient-derived xenograft models: an ideal model for preclinical study
por: Xu, Chang, et al.
Publicado: (2022)

Relationship between LAPTM4B Gene Polymorphism and Prognosis of Patients following Tumor Resection for Colorectal and Esophageal Cancers
por: Cheng, Xiaojing, et al.
Publicado: (2016)

Interleukin-26 is a promising biomarker of sepsis but is it always reliable?
por: Honore, Patrick M., et al.
Publicado: (2019)

Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis
por: Guan, Xuefeng, et al.
Publicado: (2023)

CD147 Is a Promising Target of Tumor Progression and a Prognostic Biomarker
por: Landras, Alexandra, et al.
Publicado: (2019)

CD47 expression and CD163(+) macrophages correlated with prognosis of pancreatic neuroendocrine tumor
por: Imam, Rami, et al.
Publicado: (2021)

Apoptosis-associated biomarkers in tuberculosis: promising for diagnosis and prognosis prediction
por: Shu, Chin-Chung, et al.
Publicado: (2013)

MicroRNA-7 as a Potential Biomarker for Prognosis in Pancreatic Cancer
por: Ye, Zhi-qiang, et al.
Publicado: (2020)

CD73: A Promising Biomarker in Cancer Patients
por: Turiello, Roberta, et al.
Publicado: (2020)

CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context
por: De Chiara, Loretta, et al.
Publicado: (2020)

Neoadjuvant therapy in resectable pancreatic cancer: A promising curative method to improve prognosis
por: Zhang, Hao-Qi, et al.
Publicado: (2022)

Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC
por: Li, Yilin, et al.
Publicado: (2023)

Overexpression of CD90 (Thy-1) in Pancreatic Adenocarcinoma Present in the Tumor Microenvironment
por: Zhu, Jianhui, et al.
Publicado: (2014)

Efficacy and safety of anlotinib plus camrelizumab in treating retroperitoneal soft tissue sarcomas: a single-center retrospective cohort study
por: Wu, Jianhui, et al.
Publicado: (2023)

Promising key genes associated with tumor microenvironments and prognosis of hepatocellular carcinoma
por: Pan, Long, et al.
Publicado: (2020)

Biomarkers of tumor-reactive CD4(+) and CD8(+) TILs associate with improved prognosis in endometrial cancer.
por: Palomero, Jara, et al.
Publicado: (2022)

PGM5 is a promising biomarker and may predict the prognosis of colorectal cancer patients
por: Sun, Yifan, et al.
Publicado: (2019)

CD161, a promising Immune Checkpoint, correlates with Patient Prognosis: A Pan-cancer Analysis
por: Ye, Wenrui, et al.
Publicado: (2021)

Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer
por: Li, He, et al.
Publicado: (2017)

CD26 and Cancer
por: Cordero, Oscar J.
Publicado: (2022)

Localization of CD26/DPPIV in nucleus and its nuclear translocation enhanced by anti-CD26 monoclonal antibody with anti-tumor effect
por: Yamada, Kohji, et al.
Publicado: (2009)

Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma
por: Kim, Hyung Seok, et al.
Publicado: (2023)

Endoscopic Ultrasound-Guided Radiofrequency Ablation of the Pancreatic Tumors: A Promising Tool in Management of Pancreatic Tumors
por: Changela, Kinesh, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lsrggbie5kjm950n8ukrv6dg9u